Ondansetron Orally Disintegrating Tablets

The Department of Defense is issuing Solicitation SPE2D2‑25‑R‑0018 for the procurement of covered articles and related services. Offerors must submit a single electronic copy of a Volume 1 Non‑Price Proposal and a Volume 2 Price Proposal through the DIBBS system by the closing date. The non‑price volume must contain the completed SF 1449, technical requirements, past performance, and all required evaluation documentation (initial and final evaluation results, competitive range, award selection, and lowest evaluated price). The price volume must include a distinct eleven‑digit National Drug Code (NDC) for each product, with the first five digits identifying the offeror, and all prices must be quoted in U.S. dollars. Evaluation will be based on technical acceptability (full compliance with the Statement of Work and solicitation terms) and the lowest evaluated aggregate price. The solicitation incorporates several mandatory clauses, including FAR 52.204‑18 (Cost Recovery Fee and Quarterly Sales Reports), FAR 52.252‑6 (Authorized Deviations), FAR 52.229‑11/‑12 (Foreign Procurement Taxes), and DFARS 252.204‑7019 (NIST SP 800‑171 DOD Assessment Requirements). Offerors must also comply with labor‑law provisions (Part 22) and disclose any prohibited articles or sources subject to FASCSA orders, with waivers considered only if granted. All other terms and conditions of the solicitation remain unchanged.

Notice ID

5bdd0ce9e9f34d9f911b37c1f9e94bc0

Solicitation Number

SPE2D2-25-R-0018

NAICS Code

325412

Classification Code

6505